Design Therapeutics, Inc. · NASDAQ:DSGN
Design Therapeutics, Inc. shareholders
As of Jun 30, 2026, 131 institutions reported holding Design Therapeutics, Inc., 69.2% of its shares. Largest: SR One Capital Management, LP, Logos Global Management LP and Baker Bros. Advisors LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Design Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| SR One Capital Management, LP | 6.53M | 10.4% | no change | Aug 12, 2026 |
| Logos Global Management LP | 3M | 4.8% | +1.05M | Aug 14, 2026 |
| Baker Bros. Advisors LP | 2.68M | 4.3% | +92,452 | Aug 14, 2026 |
| Driehaus Capital Management LLC | 2.66M | 4.3% | +916K | Aug 14, 2026 |
| BlackRock | 2.66M | 4.3% | +526K | Aug 7, 2026 |
| Point72 Asset Management, L.P. | 2.37M | 3.8% | −356K | Aug 14, 2026 |
| Vanguard | 2.09M | 3.3% | +392K | Aug 13, 2026 |
| Trails Edge Capital Partners, LP | 2M | 3.2% | +1.15M | Aug 14, 2026 |
| Frazier Life Sciences Management, L.P. | 1.81M | 2.9% | new | Aug 14, 2026 |
| Vivo Capital, LLC | 1.61M | 2.6% | no change | Aug 14, 2026 |